Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120296) titled 'Safety and Efficacy of Microwave Ablation for the Treatment of High-Surgical-Risk Hepatic Hemangioma' on March 11.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University
Condition:
hepatic hemangioma
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-03-01
Target Sample Size: Microwave ablation group:48;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310029
Published by HT Digital Content Services with permission from Health Daily Di...